Literature DB >> 19519245

Monoclonal antibodies against human BAP31 for immunocytochemistry.

Chaojun Song1, Fuli Wang, Zhuwei Xu, Jintao Hu, Haiqiang Tao, Angang Yang, Kun Yang, Boquan Jin.   

Abstract

Human BAP31 is a 28 kDa polytopic integral protein of the ER and part of a large BAP hetero-oligomeric complex that includes the related BAP29 protein and connections to actomyosin. BAP31 interacts with mIgD, cellubrevin, major histocompatibility complex class I, and BCL-2/BCL-X(L), and plays an important role in regulating the egress of these proteins and in apoptosis. Northern blot analyses have revealed BAP31 RNA transcripts in many tissues, including thymus, spleen, brain, kidney, testis, liver, and lung. However, prominent BAP31 protein expression analyzed by immunohistochemistry is restricted to a minority of cells in normal human tissue. Further studies should be made to verify the expression profiles of BAP31 in the protein level. Production of high affinity MAbs suitable for immunohistochemical staining has lagged. Here we generate a set of MAbs that could be used in Western blot, immunoprecipitation, and immunocytochemistry, providing a new powerful tool for investigation of expression profile of BAP31 protein and furthers the study of BAP31 functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519245     DOI: 10.1089/hyb.2008.0099

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  1 in total

1.  BAP31, a promising target for the immunotherapy of malignant melanomas.

Authors:  Shaojuan Yu; Fuli Wang; Li Fan; Yuying Wei; Haitao Li; Yuanjie Sun; Angang Yang; Boquan Jin; Chaojun Song; Kun Yang
Journal:  J Exp Clin Cancer Res       Date:  2015-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.